Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

BREAKWATER: Randomized phase 3 study of encorafenib (enco) plus cetuximab (cet) +/- chemotherapy for first-line treatment (tx) of BRAFV600E-mutant (BRAFV600) metastatic colorectal cancer (mCRC)

Scott Kopetz,Axel Grothey,Rona Yaeger,Fortunato Ciardiello,Jayesh Desai,Tae Won Kim,Tim Maughan,Eric Van Cutsem,Harpreet Singh Wasan,Takayuki Yoshino,Michelle L. Edwards,Adele Golden,Ashwin Gollerkeri,Josep Tabernero

JOURNAL OF CLINICAL ONCOLOGY（2022）

Cited 6|Views6
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined